Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
about
Acute Myeloid Leukemia: A Concise ReviewDefining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive TherapiesPost-remission therapy for acute myeloid leukemiaTargeting the innate immune system as immunotherapy for acute myeloid leukemia'Acute myeloid leukemia: a comprehensive review and 2016 update'Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party oCytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis.Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).Individualizing Therapeutic Strategies in Acute Myeloid Leukemia: Moving Beyond the 'One-Size-Fits-All' Approach.XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells.Minimal residual disease in acute myeloid leukaemiaAcute myeloid leukemia: survival analysis of patients at a university hospital of Paraná.The G⁵¹⁶T CYP2B6 germline polymorphism affects the risk of acute myeloid leukemia and is associated with specific chromosomal abnormalitiesCytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemiaPrognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profileAge and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia.Favorable clinical outcome and unique characteristics in association with Twist1 overexpression in de novo acute myeloid leukemia.The Globalization of Cooperative Groups.Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cellsExpression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML PatientsCentral nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation.High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.Karyotype complexity and prognosis in acute myeloid leukemia.Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 YearsRandomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia.Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experienceHematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients.Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patientsPrognostic significance of the Medical Research Council cytogenetic classification compared with the European LeukaemiaNet risk classification system in acute myeloid leukaemia.Acute myeloid leukemia with adverse cytogenetic riskPersistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia.Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease.Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.
P2860
Q26766719-A20193CA-CD23-4C3C-BBA3-8CCD21F9FACAQ26772235-BB04F362-D7DE-4AA0-B0F7-D9F42C39EA1AQ26995867-7CE289EB-E3F4-4671-9B78-FBC8B72075EEQ27015876-5A3C2257-4226-44F8-89BD-AA1DC587CAA6Q28072539-D77F80B0-DA05-409E-B286-3A6161540447Q29615735-22040D22-3F50-47F4-BC86-9A98EFEB6FFBQ33558748-D3334CAF-CF09-4B07-8AF0-25F760AC6FEFQ33703046-C8FA29EE-C78C-4695-9104-12744E6D5530Q33774504-176BDF84-D02A-4793-93C7-75E410612A33Q33822055-3067519D-C0F3-4C9B-9847-866B2167E7A2Q33865370-9BC7A2E1-39F8-4FD3-8295-302BED0C0215Q34100957-5CE59857-5C17-4892-9C18-B8DE34EA321EQ34179265-336EFFBB-0CC9-4A6B-8E62-DF77FF5D2513Q35054850-B8529EC2-D1D2-46C2-A82B-7C388FBA296FQ35106387-048B7296-BE27-41FA-AF7E-9905A4AD0FB9Q35146284-CA9F2EDF-6032-4A20-9031-E53FFE904DC6Q35152173-EE725EDD-4C83-4EA2-B0D9-616457FA2F5CQ35215042-89FDAA53-667D-4A0B-A212-90B15EF587FCQ35811893-AA28B29C-1E70-43BD-B7FF-8C6D6B012B13Q35863989-FBF446EC-CC7C-4C7D-AE8A-D11FFB25C524Q35981082-D6CB59CC-AAEE-4493-B30F-EDC5E07A412CQ36022536-FCCBBA86-65F2-496C-B9BF-316C89B0BD2FQ36119749-457259E5-F77C-4318-88AB-C4ABBE5319B8Q36157233-D1AC6A22-9A7B-4C3C-AF3A-CEBDAE7EF500Q36232141-C3187F8D-89CA-43DC-AD33-1B4B3FD19A06Q36254052-ED71C133-0B12-4F47-BFE6-2CD0B9C09A6DQ36483114-B19B7999-E2AA-45AF-B451-2E0C060F4183Q36511841-9B8DF80C-C751-4E8A-B3E9-97F520DAB59FQ36548075-379C16B5-D74B-401B-AE16-C975B03FE041Q36623075-97F3BBDB-8AD0-44E2-BD16-1126706E6324Q36709001-4FD2D357-FE55-4A1B-A6EC-07A4A9EF9B48Q36883252-231B9F20-A4CA-4977-926D-E531283CF598Q36961604-105203AB-9205-45D7-92E7-A82AC161AAE5Q37065843-FCDF21E5-6648-4BF1-B458-CE910220C959Q37160073-0D3D97AA-DC67-4FDE-A2E6-5E01F6D8663DQ37318679-D780E444-659C-4595-A30D-DD531E4B6374Q37338371-C883E03B-67C2-4A14-BF1B-C56765193201Q37349410-0A3A3EF9-F595-43FA-9109-2293FAE6AA29Q37362603-B673C07D-9B28-42A0-A90B-39F821E4A426Q37474559-71F9491E-054C-4755-BD83-01B858BC5225
P2860
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prognostic significance of the ...... s with acute myeloid leukemia.
@ast
Prognostic significance of the ...... s with acute myeloid leukemia.
@en
type
label
Prognostic significance of the ...... s with acute myeloid leukemia.
@ast
Prognostic significance of the ...... s with acute myeloid leukemia.
@en
prefLabel
Prognostic significance of the ...... s with acute myeloid leukemia.
@ast
Prognostic significance of the ...... s with acute myeloid leukemia.
@en
P2093
P2860
P50
P356
P1476
Prognostic significance of the ...... s with acute myeloid leukemia.
@en
P2093
Andrew J Carroll
AnneMarie W Block
Deedra Nicolet
Heiko Becker
Jonathan E Kolitz
Joseph O Moore
Kati S Maharry
Maria R Baer
Mark J Pettenati
Richard M Stone
P2860
P304
P356
10.1200/JCO.2012.43.4738
P407
P50
P577
2012-09-17T00:00:00Z